AUC |
area under the curve |
BCBM |
breast cancer brain metastasis |
CA19-9 |
cancer antigen 19-9 |
CEA |
carcinoembryonic antigen |
CI |
confidence interval |
CTC |
circulating tumor cell |
CTM |
circulating tumor microembolies |
DC |
disease control |
CA19-9 |
cancer antigen 19-9 |
CEA |
carcinoembryonic antigen |
CI |
confidence interval |
CTC |
circulating tumor cell |
CTM |
circulating tumor microembolies |
DC |
disease control |
DFS |
disease-free survival |
ECM |
extracellular matrix |
EMT |
epithelial to mesenchymal transition |
EpCAM |
epithelial cell adhesion molecule |
GC |
gastric cancer |
IHC |
immunohistochemistry |
HR |
hazard ratio |
MET |
mesenchymal to epithelial cell transition |
MHC |
major histocompatibility complex |
MP1-MMP |
membrane type 1 matrix metalloproteinase |
OS |
overall survival |
ROC |
receiver operating characteristic |
WBC |
white blood cell |